With drug costs on the rise, payors are starting to shift where patients receive infusions. Instead of hospital settings, they’re opting for ambulatory infusion centers and suites or home infusion. As this change continues, industry players need to consider the impact it can have on their businesses. This blog explores four ripple effects of this shift on key industry stakeholders.